A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.

A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.

Item
http://www.wikidata.org/entity/Q34097351
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancerChallenging and complex decisions in the management of the BRCA mutation carrierFeasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.Hereditary breast cancer: clinical, pathological and molecular characteristics.Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingRole of Breast Surgery in BRCA Mutation Carriers.Establishing a program for individuals at high risk for breast cancer.Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer.Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.Personalization of loco-regional care for primary breast cancer patients (part 2).Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral.Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation.Prophylactic mastectomy for the prevention of breast cancer: Review of the literature
P2860

A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.

Item
http://www.wikidata.org/entity/Q34097351
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@ast
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@en
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@nl
type
label
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@ast
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@en
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@nl
prefLabel
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@ast
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@en
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A simulation model to predict ...... 1 and BRCA2 mutation carriers.
@en
P2093
P2860
P304
P31
P356
10.1158/1055-9965.EPI-12-0149
P433
P478
P577
P5875
P698
P921
P932